Consensus Merck & Co., Inc.

Equities

MRK

US58933Y1055

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
132 USD +0.15% Intraday chart for Merck & Co., Inc. +6.74% +21.03%

Evolution of the average Target Price on Merck & Co., Inc.

Price target over the last 5 years

History of analyst recommendation changes

ff204ff18e4bf0d24da.csuh1pGOwMq6gVn-ZVJk-GbbquFDYTSVi5tcpYBEovo.PoqXgsHYpo3f1SmTCQ0oti-SnJQaF0Gm7uM_8dQ015Ernce038OLvu_7YQ~92f8cb85f617cbbc832fef8890219d30
Truist Securities Raises Merck Price Target to $142 From $139, Maintains Buy Rating MT
Wells Fargo Raises Price Target on Merck to $135 From $130, Maintains Equal-Weight Rating MT
Societe Generale Downgrades Merck to Sell From Hold, Raises Price Target to $104 From $103 MT
ANALYST RECOMMENDATIONS : Doordash, Merck, Eli Lilly, Walt Disney, Pearson... Our Logo
UBS Adjusts Merck & Co.'s Price Target to $148 From $135, Maintains Buy Rating MT
Wells Fargo Raises Merck's Price Target to $130 From $125, Maintains Equalweight Rating MT
Truist Securities Raises Merck's Price Target to $139 From $122, Maintains Buy Rating MT
Goldman Sachs Raises Merck's Price Target to $134 From $128, Maintains Buy Rating MT
Barclays Raises Merck's Price Target to $145 From $135, Keeps Overweight Rating MT
Jefferies Raises Merck's Price Target to $140 From $136, Keeps Buy Rating MT
Did you expect anything different? Our Logo
Futures climb following Wall St selloff after Fed holds rates steady RE
Deutsche Bank Adjusts Merck & Company Price Target to $135 From $115, Maintains Buy Rating MT
BofA Securities Raises Merck Price Target to $135 From $130, Maintains Buy Rating MT
Barclays Raises Merck's Price Target to $135 From $130, Maintains Overweight Rating MT
UBS Adjusts Merck & Company Price Target to $135 From $122, Maintains Buy Rating MT
TD Cowen Upgrades Merck to Outperform From Market Perform, Raises Price Target to $135 From $125 MT
Euphoria subsides for Triple-Witching Day Our Logo
Wall St set for higher open after Fed hints at rate cuts RE
Goldman Sachs Adjusts Merck & Co.'s Price Target to $128 From $131, Keeps Buy Rating MT
Morgan Stanley Cuts Price Target on Merck to $116 From $118, Keeps Equalweight Rating MT
ANALYST RECOMMENDATIONS : Adobe, AMD, Apple, Costco, HP, Snap... Our Logo
Investors see life through rose-colored glasses Our Logo
Deutsche Bank Initiates Coverage on Merck & Company With Buy Rating, $115 Price Target MT
ANALYST RECOMMENDATIONS : Apple, ADP, Fortinet, General Motors, S&P... Our Logo
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
132 USD
Average target price
136.2 USD
Spread / Average Target
+3.22%
High Price Target
148 USD
Spread / Highest target
+12.16%
Low Price Target
114 USD
Spread / Lowest Target
-13.60%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Merck & Co., Inc.

Truist Securities
Wells Fargo Securities
Societe Generale
UBS
Goldman Sachs
Barclays
Jefferies & Co.
Deutsche Bank Securities
BofA Securities
TD Cowen
Morgan Stanley
BMO Capital
HSBC
Atlantic Equities
Citigroup
Guggenheim
Berenberg Bank
Credit Suisse
JPMorgan Chase
Wolfe Research
SVB Securities LLC
Cantor Fitzgerald
Daiwa Securities
Cowen
SVB Leerink
Argus
RBC Capital Markets
RBC Randall Stanicky
JPMORGAN
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock
  2. Equities
  3. Stock Merck & Co., Inc. - Nyse
  4. Consensus Merck & Co., Inc.